CXCL14 Acts as a Specific Carrier of CpG DNA into Dendritic Cells and Activates Toll-like Receptor 9-mediated Adaptive Immunity

CXCL14 is a primordial chemokine that plays multiple roles in tumor suppression, autoimmune arthritis, and obesity-associated insulin resistance. However, the underlying molecular mechanisms are unclear. Here, we show that CXCL14 transports various types of CpG oligodeoxynucleotide (ODN) into the endosomes and lysosomes of bone marrow-derived dendritic cells (DCs), thereby activating Toll-like receptor 9 (TLR9). A combination of CpG ODN (ODN2395) plus CXCL14 induced robust production of IL-12 p40 by wild-type, but not Tlr9-knockout, DCs. Consistent with this, ODN2395-mediated activation of DCs was significantly attenuated in Cxcl14-knockout mice. CXCL14 bound CpG ODN with high affinity at pH 7.5, but not at pH 6.0, thereby enabling efficient delivery of CpG ODN to TLR9 in the endosome/lysosome. Furthermore, the CXCL14-CpG ODN complex specifically bound to high affinity CXCL14 receptors on DCs. Thus, CXCL14 serves as a specific carrier of CpG DNA to sensitize TLR9-mediated immunosurveillance

シシツ テイカ リョウホウ ニヨル ケイドウミャク プラーク アンテイカ ノ ヒョウカ : チョウオンパ integrated backscatter オ モチイタ カラー マッピング システム ノ カイハツ ト リンショウ オウヨウ

Background : The carotid plaque vulnerability is related to myocardial and cerebral infarction. We intended to develop an imaging system which enables to visualize tissue characteristics in the carotid plaques based on ultrasound integrated backscatter（IB）. And to test its clinical efficacy, effect of the statin therapy on the plaques was evaluated with our software. Methods and Results : Carotid ultrasound examination was performed and ultrasonographic RAW data of the plaques were obtained from８patients undergoing carotid artery endarterectomy. Tissue characteristics in the plaques of resected examples were compared with preoperative ultrasonic images and the tissue IB values corresponding to the specimens were determined for developing our imaging system. Using this system, Color-coded maps of plaques in the three patients were constructed before and after lipid lowing therapy. We could demonstrate that lipid fraction in each plaque decreased and fibrous or calcification fraction increased in the follow-up study. Conclusions : Changes in histology of carotid plaques by statin could visualized with our imaging system. This technique may become a useful tool for the management of atherosclerosis

CXCL14 Acts as a Specific Carrier of CpG DNA into Dendritic Cells and Activates Toll-like Receptor 9-mediated Adaptive Immunity

CXCL14 is a primordial chemokine that plays multiple roles in tumor suppression, autoimmune arthritis, and obesity-associated insulin resistance. However, the underlying molecular mechanisms are unclear. Here, we show that CXCL14 transports various types of CpG oligodeoxynucleotide (ODN) into the endosomes and lysosomes of bone marrow-derived dendritic cells (DCs), thereby activating Toll-like receptor 9 (TLR9). A combination of CpG ODN (ODN2395) plus CXCL14 induced robust production of IL-12 p40 by wild-type, but not Tlr9-knockout, DCs. Consistent with this, ODN2395-mediated activation of DCs was significantly attenuated in Cxcl14-knockout mice. CXCL14 bound CpG ODN with high affinity at pH 7.5, but not at pH 6.0, thereby enabling efficient delivery of CpG ODN to TLR9 in the endosome/lysosome. Furthermore, the CXCL14-CpG ODN complex specifically bound to high affinity CXCL14 receptors on DCs. Thus, CXCL14 serves as a specific carrier of CpG DNA to sensitize TLR9-mediated immunosurveillance

Double-armed and tetra-armed cyclen-based cryptands

<p>Double-armed and tetra-armed cyclen-based cryptands (<b>1a</b>–<b>1d</b> and <b>2</b>) that bridge two aromatic rings by diethyleneoxy and triethyleneoxy units were prepared. The CSI-MS of 1:1 mixtures ([Ag⁺]/[ligand]) indicated that these new cryptands form 1:1 complexes with Ag⁺. The log <i>K</i> values for the interaction between Ag⁺ and <b>2</b> was greater than those of <b>1a</b>–<b>1d</b>, double-armed cyclens (<b>3a</b>–<b>3c</b> and <b>4</b>), and tetra-armed cyclen (<b>5</b>). The Ag⁺-ion-induced ¹H NMR spectral changes suggest that the Ag⁺–<i>π</i> interactions of the Ag⁺ complexes with the cryptands (<b>1a</b>–<b>1d</b> and <b>2</b>) are stronger than those in Ag⁺/double-armed and tetra-armed cyclens. To visualise the Ag⁺−<i>π</i> interactions, the isosurfaces of the LUMO and HOMOs of the Ag⁺ complexes were calculated at the B3LYP/3–21G(*) theoretical level. The LUMO of the Ag⁺ ion is distorted by interaction with the HOMOs of the aromatic side arms. The calculations reveal Ag⁺−<i>π</i> interactions between the Ag⁺ ion and the aromatic side arms, and these are shown graphically.</p

Double-armed and tetra-armed cyclen-based cryptands

<p>Double-armed and tetra-armed cyclen-based cryptands (<b>1a</b>–<b>1d</b> and <b>2</b>) that bridge two aromatic rings by diethyleneoxy and triethyleneoxy units were prepared. The CSI-MS of 1:1 mixtures ([Ag⁺]/[ligand]) indicated that these new cryptands form 1:1 complexes with Ag⁺. The log <i>K</i> values for the interaction between Ag⁺ and <b>2</b> was greater than those of <b>1a</b>–<b>1d</b>, double-armed cyclens (<b>3a</b>–<b>3c</b> and <b>4</b>), and tetra-armed cyclen (<b>5</b>). The Ag⁺-ion-induced ¹H NMR spectral changes suggest that the Ag⁺–<i>π</i> interactions of the Ag⁺ complexes with the cryptands (<b>1a</b>–<b>1d</b> and <b>2</b>) are stronger than those in Ag⁺/double-armed and tetra-armed cyclens. To visualise the Ag⁺−<i>π</i> interactions, the isosurfaces of the LUMO and HOMOs of the Ag⁺ complexes were calculated at the B3LYP/3–21G(*) theoretical level. The LUMO of the Ag⁺ ion is distorted by interaction with the HOMOs of the aromatic side arms. The calculations reveal Ag⁺−<i>π</i> interactions between the Ag⁺ ion and the aromatic side arms, and these are shown graphically.</p